1 completed, 1 recruiting, 1 terminated. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow L-folinic acid: new trials by email Literature Review of L-folinic acid trials Research Report on L-folinic acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer Panitumumab, Irinotecan, 5-fluorouracil - Colorectal Cancer Stage IV | Phase 3 | Recruiting | National Cancer Institute, Naples | 500 | 2024-06-12 | 2024-07-19 |
| Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive Cancers 5-Fluorouracil, L-Folinic acid, Oxaliplatin - Digestive Cancer | Phase 1 / Phase 2 | Terminated | Institut Cancerologie de l'Ouest | 34 | 2017-05-24 | 2022-04-25 |
| Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers Active Symptom Control, L-folinic acid, 5 FU - Biliary Tract Cancer, Gallbladder Cancer | Phase 3 | Completed | The Christie NHS Foundation Trust | 162 | 2014-02-01 | 2020-01-28 |
Biliary Tract Neoplasms (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Gallbladder Neoplasms (1) · Gastrointestinal Neoplasms (1)
Institut Cancerologie de l'Ouest (1) · National Cancer Institute, Naples (1) · The Christie NHS Foundation Trust (1)
France (1) · Italy (1) · United Kingdom (1)
Juan Valle, Prof (1)